NDC 59651-367

Vigabatrin

Vigabatrin

Vigabatrin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Vigabatrin.

Product ID59651-367_4aaea88b-e0fd-45e3-bb02-604bf8ee9b5b
NDC59651-367
Product TypeHuman Prescription Drug
Proprietary NameVigabatrin
Generic NameVigabatrin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-05-10
Marketing CategoryANDA /
Application NumberANDA215601
Labeler NameAurobindo Pharma Limited
Substance NameVIGABATRIN
Active Ingredient Strength500 mg/1
Pharm ClassesAnti-epileptic Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 59651-367-01

1 BOTTLE in 1 CARTON (59651-367-01) > 100 TABLET in 1 BOTTLE
Marketing Start Date2022-05-10
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Vigabatrin" or generic name "Vigabatrin"

NDCBrand NameGeneric Name
0591-3851VigabatrinVigabatrin
0591-3955vigabatrinvigabatrin
16729-521VigabatrinVigabatrin
43598-651VigabatrinVigabatrin
43598-697VigabatrinVigabatrin
49884-358VIGABATRINvigabatrin
59651-366VigabatrinVigabatrin
59651-367VigabatrinVigabatrin
67877-674VIGABATRINVIGABATRIN
68180-521VigabatrinVigabatrin
69097-964VIGABATRINvigabatrin
69238-1425VigabatrinVigabatrin
67386-111SABRILvigabatrin
67386-211SABRILvigabatrin
31722-009vigabatrin for oral solutionvigabatrin
0054-0702Vigabatrin for oral solution USP, 500 mgVigabatrin
0245-0556VIGADRONEvigabatrin

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.